Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole vs Voriconazole in Japanese Subjects with Deep-seated Fungal Infection
NCT02180165Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of posaconazole in invasive aspergillosis (IA), chronic pulmonary aspergillosis (CPA), mucormycosis, fusariosis, sponsored by Merck & Co.. Started Jul 2014; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive aspergillosis (IA)chronic pulmonary aspergillosis (CPA)mucormycosisfusariosis
Beyond the preview
Go deeper on NCT02180165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180165.